Evidence map›Paper›PMID 25206795›Full record

ArticleNeural regeneration research2014

Aspartic acid in the hippocampus: a biomarker for postoperative cognitive dysfunction.

Rong Hu, Dong Huang, Jianbin Tong, Qin Liao, Zhonghua Hu, Wen Ouyang

Open access · goldAbstract read
In one paragraph

Article in Neural regeneration research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. A metabolite panel that differentiates Alzheimer's disease from other dementia types.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022
    Article
  4. Article
  5. Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rong HuDepartment of Anesthesia, Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Dong HuangDepartment of Anesthesia, Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Jianbin TongDepartment of Anatomy & Neurobiology, Xiangya School of Medicine, Central South University, Changsha, Hunan Province, China.
Qin LiaoDepartment of Anesthesia, Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Zhonghua HuDepartment of Anesthesia, Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Wen OuyangDepartment of Anesthesia, Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Central South University · CNThird Xiangya Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study established an aged rat model of cognitive dysfunction using anesthesia with 2% isoflurane and 80% oxygen for 2 hours. Twenty-four hours later, Y-maze test results showed that isoflurane significantly impaired cognitive function in aged rats. Gas chromatography-mass spectrometry results showed that isoflurane also significantly increased the levels of N,N-diethylacetamide, n-ethylacetamide, aspartic acid, malic acid and arabinonic acid in the hippocampus of isoflurane-treated rats. Moreover, aspartic acid, N,N-diethylacetamide, n-ethylacetamide and malic acid concentration was positively correlated with the degree of cognitive dysfunction in the isoflurane-treated rats. It is evident that hippocampal metabolite changes are involved in the formation of cognitive dysfunction after isoflurane anesthesia. To further verify these results, this study cultured hippocampal neurons in vitro, which were then treated with aspartic acid (100 μmol/L). Results suggested that aspartic acid concentration in the hippocampus may be a biomarker for predicting the occurrence and disease progress of cognitive dysfunction.

Indexed as

anesthesiaaspartic acidbrain impairmentgas chromatography-mass spectrometryhippocampal metabolitesisofluranemetabonomicsnerve regenerationneural regenerationNSFC grantpostoperative cognitive dysfunction

Identifiers

PMID25206795
PMCPMC4146156
OpenAlexW2000532971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.